What is MNTS's health score?

Momentus Inc. (MNTS) has a TradeApes health score of 34 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MNTS's estimated fair value?

Based on our 5-year discounted cash flow model, Momentus Inc.'s estimated fair value is $6.34 per share, representing a -57.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MNTS undervalued or overvalued?

Our model currently rates MNTS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MNTS... Refresh in a moment for the full analysis.

Momentus Inc. (MNTS)

Consumer Cyclical Overvalued low weak

$14.91

Updated: 2026-06-07

TradeApes Score

Financial Strength

10 Stressed

Operating Trend

20 Stressed

Relative Value

40 Weak

Capital Allocation

65 Healthy

Risk

70 Healthy

Est. Fair Value $6.34

DCF Upside -57.5%

Sector Rank #616 of 3288

Key Findings

+ Active buybacks — share count declining, capital returned to owners

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.